• 00:00 1.
    index 1
  • 00:10 2.
    ** after 20230522 lab meeting.pptx
  • 00:22 3.
    Slide 1
  • 00:55 4.
    Characteristics of circNDUFB2 in NSCLC cells
  • 02:21 5.
    Characteristics of circNDUFB2 in NSCLC cells
  • 03:03 6.
    CircNDUFB2 inhibited NSCLC progression
  • 03:55 7.
    CircNDUFB2 inhibited NSCLC migration, invasion and metastasis
  • 04:35 8.
    CircNDUFB2 interacted with IGF2BPs in NSCLC cells
  • 08:02 9.
    CircNDUFB2 enhanced IGF2BPs ubiquitination and degradation
  • 15:00 10.
    TRIM25 mediated IGF2BPs ubiquitination
  • 17:32 11.
    CircNDUFB2 enhances interaction between IGF2BPs and TRIM25
  • 17:35 12.
    TRIM25 mediated IGF2BPs ubiquitination
  • 21:31 13.
    CircNDUFB2 enhances interaction between IGF2BPs and TRIM25
  • 24:11 14.
    CircNDUFB2 facilitated ubiquitination degradation of IGF2BPs by forming a TRIM25/circNDUFB2/IGF2BPs complex
  • 25:16 15.
    CircNDUFB2 tiggered cellular immune responses
  • 26:37 16.
    CircNDUFB2 tiggered cellular immune responses
  • 26:43 17.
    CircNDUFB2 tiggered cellular immune responses
  • 36:11 18.
    CircNDUFB2 tiggered cellular immune responses
  • 40:04 19.
    RIG-I
  • 40:04 20.
    circNDUFB2 activated RIG-I
  • 40:05 21.
    RIG-I
  • 40:07 22.
    CircNDUFB2 tiggered cellular immune responses
  • 40:40 23.
    RIG-I
  • 42:30 24.
    Immune responses of circNDUFB2 inhibit NSCLC progression
  • 42:31 25.
    circNDUFB2 activated RIG-I
  • 42:32 26.
    circNDUFB2 activated RIG-I
  • 42:34 27.
    RIG-I
  • 43:02 28.
    circNDUFB2 activated RIG-I
  • 45:11 29.
    RIG-I
  • 45:14 30.
    circNDUFB2 activated RIG-I
  • 47:23 31.
    circNDUFB2 activated RIG-I
  • 47:24 32.
    Immune responses of circNDUFB2 inhibit NSCLC progression
  • 47:25 33.
    circNDUFB2 activated RIG-I
  • 50:17 34.
    Immune responses of circNDUFB2 inhibit NSCLC progression
  • 50:17 35.
    Inhibitory effects of circNDUFB2 on NSCLC progression
  • 50:18 36.
    Immune responses of circNDUFB2 inhibit NSCLC progression
  • 52:00 37.
    Inhibitory effects of circNDUFB2 on NSCLC progression
  • 52:57 38.
    Slide 18
  • 52:58 39.
    ** after 20230522 lab meeting.pptx
  • Index
  • Notes
  • Comment
  • Fullscreen
20230522 lab meeting_俐妤
Duration: 53:01, Browse: 181, Last Updated: 2023-05-22
    • 00:00 1.
      index 1
    • 00:10 2.
      ** after 20230522 lab meeting.pptx
    • 00:22 3.
      Slide 1
    • 00:55 4.
      Characteristics of circNDUFB2 in NSCLC cells
    • 02:21 5.
      Characteristics of circNDUFB2 in NSCLC cells
    • 03:03 6.
      CircNDUFB2 inhibited NSCLC progression
    • 03:55 7.
      CircNDUFB2 inhibited NSCLC migration, invasion and metastasis
    • 04:35 8.
      CircNDUFB2 interacted with IGF2BPs in NSCLC cells
    • 08:02 9.
      CircNDUFB2 enhanced IGF2BPs ubiquitination and degradation
    • 15:00 10.
      TRIM25 mediated IGF2BPs ubiquitination
    • 17:32 11.
      CircNDUFB2 enhances interaction between IGF2BPs and TRIM25
    • 17:35 12.
      TRIM25 mediated IGF2BPs ubiquitination
    • 21:31 13.
      CircNDUFB2 enhances interaction between IGF2BPs and TRIM25
    • 24:11 14.
      CircNDUFB2 facilitated ubiquitination degradation of IGF2BPs by forming a TRIM25/circNDUFB2/IGF2BPs complex
    • 25:16 15.
      CircNDUFB2 tiggered cellular immune responses
    • 26:37 16.
      CircNDUFB2 tiggered cellular immune responses
    • 26:43 17.
      CircNDUFB2 tiggered cellular immune responses
    • 36:11 18.
      CircNDUFB2 tiggered cellular immune responses
    • 40:04 19.
      RIG-I
    • 40:04 20.
      circNDUFB2 activated RIG-I
    • 40:05 21.
      RIG-I
    • 40:07 22.
      CircNDUFB2 tiggered cellular immune responses
    • 40:40 23.
      RIG-I
    • 42:30 24.
      Immune responses of circNDUFB2 inhibit NSCLC progression
    • 42:31 25.
      circNDUFB2 activated RIG-I
    • 42:32 26.
      circNDUFB2 activated RIG-I
    • 42:34 27.
      RIG-I
    • 43:02 28.
      circNDUFB2 activated RIG-I
    • 45:11 29.
      RIG-I
    • 45:14 30.
      circNDUFB2 activated RIG-I
    • 47:23 31.
      circNDUFB2 activated RIG-I
    • 47:24 32.
      Immune responses of circNDUFB2 inhibit NSCLC progression
    • 47:25 33.
      circNDUFB2 activated RIG-I
    • 50:17 34.
      Immune responses of circNDUFB2 inhibit NSCLC progression
    • 50:17 35.
      Inhibitory effects of circNDUFB2 on NSCLC progression
    • 50:18 36.
      Immune responses of circNDUFB2 inhibit NSCLC progression
    • 52:00 37.
      Inhibitory effects of circNDUFB2 on NSCLC progression
    • 52:57 38.
      Slide 18
    • 52:58 39.
      ** after 20230522 lab meeting.pptx
    Location
    Folder name
    2023
    Author
    林俐妤
    Branch
    賴亮全教授
    Created
    2023-05-22 14:10:24
    Last Updated
    2023-05-22 14:25:53
    Duration
    53:01